Monoclonal Antibody-Mediated CD200 Receptor Signaling Suppresses Macrophage Activation and Tissue Damage in Experimental Autoimmune Uveoretinitis

Overview of attention for article published in American Journal of Pathology, June 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 117 Dimensions

Readers on

mendeley: 68 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

CD200R AGONIST ANTIBODIES AND USES THEREOF

Application WO-2020055943-A1

World Intellectual Property Organisation (WIPO)

DNA APTAMERS SPECIFIC TO CD200R1 AND THEIR THERAPEUTIC USES

Application EP-3126500-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.